News for iTeos Therapeutics, Inc. (ITOS)

The consensus price target hints at a 212.5% upside potential for iTeos Therapeutics (ITOS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

iTeos Therapeutics (ITOS) reports Q4 GAAP EPS of -$1.01, beating estimates by $0.05. Cash & investments grow to $655M YoY.

- Topline interim dataset from GALAXIES Lung-201 with >240 patients anticipated in 2Q25- Interim datasets from GALAXIES H&N-202 and TIG-006 HNSCC with ~200 pati

iTeos' Belrestotug shows efficacy in trials, backed by a strong cash runway. Learn why ITOS stock might thrive with strategic GSK collaboration.

On December 31, 2024, TANG CAPITAL MANAGEMENT LLC (Trades, Portfolio) executed a substantial reduction in its holdings of ITeos Therapeutics Inc (ITOS). The fir

iTeos Therapeutics (ITOS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

iTeos Announces 2025 Strategic Priorities and Anticipated Milestones

**media[509156]**

iTeos Therapeutics has potential lung cancer treatment despite issues and strong financial position. Read here to know why we are bullish on ITOS stock.

**media[490609]**

**media[476517]**

On November 14, 2024, BIOTECHNOLOGY VALUE FUND L P (Trades, Portfolio) executed a significant transaction involving ITeos Therapeutics Inc (ITOS). The firm adde

On November 19, 2024, Matthew Gall, Chief Financial Officer of ITeos Therapeutics Inc, purchased 5,000 shares of the company, as reported in the SEC Filing. Fol

Iteos Therapeutics stock hits 52-week low at $8.39

Iteos Therapeutics stock hits 52-week low at $8.49

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling around 1% on Monday. The Dow traded up 0.29% to 41,512.19 while the NASDAQ f...

U.S. stock futures were mixed this morning, with the Dow futures gaining around 100 points on Monday. Shares of iTeos Therapeutics, Inc. ITOS fell sharply in t...

Shares of Exicure, Inc. XCUR rose sharply in today's pre-market trading after the company entered into debt-for-equity exchange agreements and regained Nasdaq c...

This is our list of the best health care stocks based on the highest return over the last 30 days.